CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts

Hiroshi Takayanagi, Sunhwa Kim, Takako Koga et al. · Developmental Cell · 2002 · 2.7K citations · Full text

Medicine, Cell Biology, Molecular Biology +16

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

Xosé S. Puente, Magda Pinyol, Vı́ctor Quesada et al. · Nature · 2011 · 1.5K citations · Full text

Medicine, Molecular Biology, Molecular Genetics +17

The molecular classification of multiple myeloma

Fenghuang Zhan, Yongsheng Huang, Simona Colla et al. · Blood · 2006 · 1.1K citations · Full text

Medicine, Molecular Biology, Oncology +14

A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1

John D. Shaughnessy, Fenghuang Zhan, Bart Burington et al. · Blood · 2006 · 916 citations

Life Sciences, Genetics, Molecular Biology +12

DC-STAMP is essential for cell–cell fusion in osteoclasts and foreign body giant cells

Mitsuru Yagi, Takeshi Miyamoto, Yumi Sawatani et al. · The Journal of Experimental Medicine · 2005 · 892 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8